Sehested M, Bindslev N, Demant E J, Skovsgaard T, Jensen P B
Department of Pathology, Herlev University Hospital, Denmark.
Biochem Pharmacol. 1989 Sep 15;38(18):3017-27. doi: 10.1016/0006-2952(89)90010-5.
Tumor cell resistance to anthracyclines, epipodophyllotoxins and vinca alkaloids, called multi-drug resistance (MDR) is intimately linked to changes in the plasma membrane which facilitate an increased energy dependent drug extrusion in the resistant cell compared to the wild type cell. Isolated plasma membrane vesicles from wild type Ehrlich ascites tumor cells (EHR2) and the daunorubicin (DNR) resistant subline EHR2/DNR+ were utilised to study binding and possible transport of DNR and vincristine (VCR). A significant ATP enhanced increase in VCR binding to vesicles from EHR2/DNR+ compared to EHR2 was demonstrated. Furthermore, an increase in ATP enhanced VCR binding in proportion to content of the MDR associated P-glycoprotein was seen in plasma membrane vesicles prepared from various benign human endocrine tumors. VCR binding to EHR2/DNR+ vesicles was inhibited by other vinca alkaloids greater than actinomycin D greater than colchicine greater than anthracyclines, with 35-75 microM concentrations of anthracyclines needed for 50% inhibition. VCR binding to EHR2/DNR+ vesicles was pH and temperature dependent with an activation energy of -30 kJ/mol and was decreased by replacement of Na+ with K+ and by addition of Ca2+. Preincubation of vesicles with monoclonal antibody against the C terminal of P-glycoprotein had no effect on VCR binding and osmolality tests failed to show genuine transmembranal transport of VCR. DNR binding was similar in plasma membrane vesicles from both cell lines, and showed none of the characteristics mentioned for VCR. Furthermore, a radiolabeled N-hydroxysuccinimide ester derivative of doxorubicin, which inhibited VCR binding to EHR2/DNR+ membranes to an even greater extent than doxorubicin, labeled plasma membrane proteins from EHR2 and EHR2/DNR+ identically and did not demonstrate any binding to P-glycoprotein. Therefore, even though the study confirms the close link between vinca alkaloid binding and P-glycoprotein, it could not detect a similar association between anthracyclines and P-glycoprotein thus attesting to the complexity of the MDR phenotype.
肿瘤细胞对蒽环类药物、鬼臼毒素和长春花生物碱产生的耐药性,即多药耐药性(MDR),与质膜变化密切相关,与野生型细胞相比,耐药细胞中能量依赖性药物外排增加。利用从野生型艾氏腹水瘤细胞(EHR2)和柔红霉素(DNR)耐药亚系EHR2/DNR+分离的质膜囊泡,研究DNR和长春新碱(VCR)的结合及可能的转运。结果表明,与EHR2相比,ATP显著增强了VCR与EHR2/DNR+囊泡的结合。此外,在从各种良性人类内分泌肿瘤制备的质膜囊泡中,观察到ATP增强的VCR结合与MDR相关P-糖蛋白的含量成比例增加。VCR与EHR2/DNR+囊泡的结合受其他长春花生物碱抑制作用大于放线菌素D大于秋水仙碱大于蒽环类药物,50%抑制需要35 - 75 microM浓度的蒽环类药物。VCR与EHR2/DNR+囊泡的结合依赖于pH和温度,活化能为 - 30 kJ/mol,用K+替代Na+以及添加Ca2+会使其降低。用针对P-糖蛋白C末端的单克隆抗体对囊泡进行预孵育对VCR结合没有影响,渗透压测试未能显示VCR的真正跨膜转运。两种细胞系的质膜囊泡中DNR结合情况相似,且没有显示出VCR所具有的上述特征。此外,一种阿霉素的放射性标记N-羟基琥珀酰亚胺酯衍生物,其抑制VCR与EHR2/DNR+膜结合的程度甚至比阿霉素更大,它对EHR2和EHR2/DNR+的质膜蛋白标记相同,且未显示出与P-糖蛋白有任何结合。因此,尽管该研究证实了长春花生物碱结合与P-糖蛋白之间的紧密联系,但未检测到蒽环类药物与P-糖蛋白之间存在类似关联,从而证明了MDR表型的复杂性。